Indivior Extends Leadership Position in Substance Use Disorder Treatment with Exclusive Agreement for Leading Asset Targeting Cannabis-Related Disorders Read more
BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA Read more
Moderna and Medison Pharma partner to commercialize Moderna’s COVID-19 vaccine across Central Eastern Europe and Israel Read more
FDA grants accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease Read more
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication Read more
Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis Read more